Group One Trading, L.P. Abeona Therapeutics Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$3.17 - $8.05 $14,347 - $36,434
4,526 Added 257.6%
6,283 $26,000
Q1 2024

May 10, 2024
BUY
$4.07 - $8.68 $4,033 - $8,601
991 Added 129.37%
1,757 $12,000
Q4 2023

Feb 14, 2024
SELL
$3.71 - $5.14 $34,258 - $47,462
-9,234 Reduced 92.34%
766 $3,000
Q3 2023

Nov 09, 2023
BUY
$2.98 - $4.43 $29,800 - $44,300
10,000 New
10,000 $42,000
Q3 2022

Nov 09, 2022
BUY
$2.79 - $5.56 $9,756 - $19,443
3,497 New
3,497 $11,000

Others Institutions Holding ABEO

# of Institutions
61
Shares Held
26.9M
Call Options Held
614K
Put Options Held
45K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email